Total Funding
55
62
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
123254
Drug Discovery and Biotechnology
- Mark Bernard: President, CEO and Co-Founder
About the Company
Capienda saves time (1-2 yrs) and cost ($1 Billion) to develop new medicines by opening a key bottleneck in drug discovery. Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials. * First high-throughput kinetics system for small molecule drugs. * 48x throughput of Biacore. * Specialist
scientists not required.
Product is laboratory instrument system + assay chemicals (recurring revenues).
